Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.

Grossman SA, Ye X, Piantadosi S, Desideri S, Nabors LB, Rosenfeld M, Fisher J; NABTT CNS Consortium.

Clin Cancer Res. 2010 Apr 15;16(8):2443-9. doi: 10.1158/1078-0432.CCR-09-3106. Epub 2010 Apr 6.

3.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

4.

Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.

Cao JQ, Fisher BJ, Bauman GS, Megyesi JF, Watling CJ, Macdonald DR.

J Neurooncol. 2012 Apr;107(2):395-405. doi: 10.1007/s11060-011-0766-3. Epub 2011 Nov 22. Review.

PMID:
22105851
5.

Chemotherapy for malignant gliomas.

Marosi C.

Wien Med Wochenschr. 2006 Jun;156(11-12):346-50. Review.

PMID:
16944366
6.

Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients.

Mehta M, Wen P, Nishikawa R, Reardon D, Peters K.

Crit Rev Oncol Hematol. 2017 Mar;111:60-65. doi: 10.1016/j.critrevonc.2017.01.005. Epub 2017 Jan 22. Review.

7.

The evolution of chemoradiation for glioblastoma: a modern success story.

Mirimanoff RO.

Curr Oncol Rep. 2006 Jan;8(1):50-3. Review.

PMID:
16464403
8.

Dose-dense temozolomide: is it still promising?

Nagane M.

Neurol Med Chir (Tokyo). 2015;55(1):38-49. doi: 10.2176/nmc.ra.2014-0277. Epub 2014 Dec 20. Review.

9.

Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve.

Koukourakis MI, Mitrakas AG, Giatromanolaki A.

Br J Cancer. 2016 Mar 1;114(5):485-96. doi: 10.1038/bjc.2016.19. Epub 2016 Feb 18. Review.

10.

Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline.

Sulman EP, Ismaila N, Armstrong TS, Tsien C, Batchelor TT, Cloughesy T, Galanis E, Gilbert M, Gondi V, Lovely M, Mehta M, Mumber MP, Sloan A, Chang SM.

J Clin Oncol. 2017 Jan 20;35(3):361-369. doi: 10.1200/JCO.2016.70.7562. Epub 2016 Nov 28. Review.

PMID:
27893327
11.

Pharmacotherapies for the treatment of glioblastoma - current evidence and perspectives.

Seystahl K, Gramatzki D, Roth P, Weller M.

Expert Opin Pharmacother. 2016 Jun;17(9):1259-70. doi: 10.1080/14656566.2016.1176146. Epub 2016 Apr 21. Review.

12.

Role of temozolomide in pediatric brain tumors.

Barone G, Maurizi P, Tamburrini G, Riccardi R.

Childs Nerv Syst. 2006 Jul;22(7):652-61. Epub 2006 Mar 25. Review.

PMID:
16565851
13.

Advances in the treatment of primary brain tumors: dawn of a new era?

Gilbert MR.

Curr Oncol Rep. 2006 Jan;8(1):45-9. Review.

PMID:
16464402
14.

An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.

Neagu MR, Reardon DA.

Curr Treat Options Oncol. 2015 Nov;16(11):54. doi: 10.1007/s11864-015-0371-3. Review.

PMID:
26454859
15.

Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.

Singhal N, Selva-Nayagam S, Brown MP.

J Neurooncol. 2007 Nov;85(2):229-30. Epub 2007 May 26. Review.

PMID:
17530175
16.

Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival.

dos Santos MA, Pignon JP, Blanchard P, Lefeuvre D, Levy A, Touat M, Louvel G, Dhermain F, Soria JC, Deutsch E, Le Teuff G.

J Neurooncol. 2015 Jun;123(2):307-14. doi: 10.1007/s11060-015-1802-5. Epub 2015 May 15. Review.

PMID:
25975195
17.

[Reirradiation of recurrent glioblastoma].

Seewald D.

Wien Med Wochenschr. 2011 Jan;161(1-2):22-5. doi: 10.1007/s10354-010-0862-6. Review. German.

PMID:
21312096
18.

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.

Trusheim J, Dunbar E, Battiste J, Iwamoto F, Mohile N, Damek D, Bota DA, Connelly J.

CNS Oncol. 2017 Jan;6(1):29-43. doi: 10.2217/cns-2016-0032. Epub 2016 Sep 15. Review.

19.

What next for newly diagnosed glioblastoma?

Domingo-Musibay E, Galanis E.

Future Oncol. 2015;11(24):3273-83. doi: 10.2217/fon.15.258. Epub 2015 Nov 12. Review.

20.

Standards of care for treatment of recurrent glioblastoma--are we there yet?

Weller M, Cloughesy T, Perry JR, Wick W.

Neuro Oncol. 2013 Jan;15(1):4-27. doi: 10.1093/neuonc/nos273. Epub 2012 Nov 7. Review.

Supplemental Content

Support Center